Treatment of Acute Myeloid Leukemia with 20–30% Bone Marrow Blasts

The transition of patients with ≥20% <30% bone marrow (BM) blast from the FAB category of myelodysplasia to the family of acute myeloid leukemia (AML) according to the recent WHO classification has not resolved the argument as to whether the natural history and responsiveness to therapy of these...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Maurillo, Luca, Buccisano, Francesco, Del Principe, Maria Ilaria, Sarlo, Chiara, Di Caprio, Luigi, Ditto, Concetta, Giannotti, Federica, Nasso, Daniela, Ceresoli, Eleonora, Postorino, Massimiliano, Refrigeri, Marco, Amadori, Sergio, Venditti, Adriano
Médium: Artigo
Jazyk:Inglês
Vydáno: Università Cattolica del Sacro Cuore 2013
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3684350/
https://ncbi.nlm.nih.gov/pubmed/23795270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2013.032
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky